Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test represents a breakthrough in tuberculosis diagnosis and treatment planning. This sophisticated diagnostic tool utilizes automated fluorescent technology to evaluate Mycobacterium tuberculosis complex susceptibility to 12 essential anti-tuberculosis medications. As drug-resistant TB strains continue to emerge globally, this comprehensive panel provides critical information that directly impacts treatment success and patient outcomes.
What This Advanced Test Measures
This comprehensive panel evaluates bacterial susceptibility to the following 12 critical anti-tuberculosis drugs:
- Streptomycin – First-line aminoglycoside antibiotic
- Isoniazid – Primary first-line TB medication
- Rifampicin – Cornerstone of TB treatment regimens
- Ethambutol – Essential first-line anti-TB drug
- Pyrazinamide – Critical for active TB treatment
- Clofazimine – Second-line anti-mycobacterial agent
- Ethionamide – Important second-line medication
- Capreomycin – Injectable second-line antibiotic
- Kanamycin – Aminoglycoside for resistant cases
- Amikacin – Broad-spectrum aminoglycoside
- Ofloxacin – Fluoroquinolone antibiotic
- PAS (Para-aminosalicylic acid) – Second-line anti-TB agent
Who Should Consider This Test?
This comprehensive drug sensitivity testing is particularly important for individuals experiencing:
- Persistent cough lasting more than 3 weeks
- Unexplained weight loss and fatigue
- Night sweats and fever patterns
- Chest pain and breathing difficulties
- Previous TB treatment failure
- Known exposure to drug-resistant TB strains
- Immunocompromised conditions increasing TB risk
- Healthcare workers with potential TB exposure
Clinical Indications and Benefits
The Cultured AFB Antitubercular DST Rapid 12 Drugs Panel offers numerous clinical advantages:
- Personalized Treatment Planning – Enables physicians to design customized treatment regimens based on specific drug susceptibility patterns
- Prevention of Treatment Failure – Identifies drug resistance early to avoid ineffective treatment courses
- Reduced Transmission Risk – Helps contain drug-resistant strains through appropriate isolation and treatment
- Cost-Effective Care – Prevents unnecessary medication expenses by targeting only effective drugs
- Improved Patient Outcomes – Significantly increases treatment success rates for drug-resistant TB
Understanding Your Test Results
Your test results will provide detailed information about which anti-tuberculosis medications are effective against your specific Mycobacterium tuberculosis strain. The report categorizes drugs as:
- Susceptible – The medication is effective against your TB strain
- Resistant – The medication will not be effective for treatment
- Intermediate – The medication may have limited effectiveness
Your physician will use these results to create a personalized treatment plan that combines multiple effective medications to ensure complete eradication of the tuberculosis infection while minimizing side effects and treatment duration.
Test Pricing Information
| Test Name | Regular Price | Discount Price |
|---|---|---|
| Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test | $576 USD | $412 USD |
Convenient Testing Across the USA
We have diagnostic centers conveniently located throughout the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure accurate testing with rapid turnaround times.
Sample Collection and Processing
For this test, we require submission of pure growth of Mycobacterium tuberculosis complex on appropriate media in a sterile screw-capped container within a sealed plastic bag. Samples should be shipped refrigerated. Alternatively, when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in our laboratory from previously submitted specimens will be processed for antitubercular sensitivity testing.
Turnaround Time: Samples accepted daily by 3:30 PM | Reports available in 21 days
No special preparation required – Simply consult with your healthcare provider for proper sample collection guidance.
Take Control of Your Tuberculosis Treatment Today
Don’t let drug-resistant tuberculosis compromise your health and treatment outcomes. Our comprehensive 12-drug panel provides the critical information needed for effective treatment planning. With branches across the United States and experienced medical professionals ready to assist, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our healthcare specialists about your testing needs.
Early detection of drug resistance is crucial for successful tuberculosis treatment. Book your Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test now and take the first step toward personalized, effective TB treatment.
